Aortic aneurysm is a medical condition, in which aorta, gets enlarged. Abdominal and Thoracic are two categories of aortic aneurysm. These conditions can lead to abdominal pain, low blood pressure, loss of consciousness or even death. Endovascular aneurysm repair (EVAR) is a minimally invasive surgical method to treat abdominal and thoracic aortic aneurysm. It is an alternative to open surgery for abdominal aortic aneurysm (AAA), which makes it relatively safe and less time consuming. However, not all patients suffering from aneurysm are suitable for EVAR. Also, it is difficult to treat aneurysm near or on the kidney using EVAR.

Increasing demand for minimally invasive surgeries to treat various medical conditions to boost growth of endovascular aneurysm repair (EVAR) market

Get PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1339

According to a study published in the New England Journal of Medicine, 2016, the number of patients opting for endovascular aneurysm repair has increased significantly during 2005–2012. For instance, in 2005, the percentage of patients in the U.S. suffering from aneurysm opting for EVAR was around 50%, which increased to 75.4% in 2012. A similar pattern was observed in England. Increasing consumer inclination towards this revolutionary procedure is attributed to it being a minimally-invasive method of treatment that requires minimal stay in hospitals, smaller incisions, less scaring, and aids in rapid recovery. This is expected to aid in growth of the market.

Endovascular Aneurysm Repair (EVAR) Market Taxonomy

By Product Type
Fenestrated Stent Graft
Adjunctive Stent Graft
Branched Stent Graft
Others
By Indication
Abdominal Aortic Aneurysm (AAA)
Thoracic Aortic aneurysm (TAA)
Descending Aortic Aneurysm
Ascending Aortic Aneurysm
By End Users
Hospitals
Ambulatory care services
Specialty clinics
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East
Africa
North America is expected to hold a dominant position in global endovascular aneurysm repair (EVAR) market over the forecast period

North America accounted for the largest share in the global endovascular aneurysm market in 2016, owing to increasing prevalence of aneurysms and rising geriatric population, which is more prone to this condition. According to the New England Journal of Medicine, 2016, 278,921 patients underwent repair of abdominal aortic aneurysm in the U.S. during 2005–2012. According to Centers for Disease Control and Prevention (CDC), in 2014, aortic aneurysms led to death of 9,863 in the U.S. Moreover, aneurysm is more prevalent is geriatric population i.e. 50 years and above. According to the U.S. Population Reference Bureau, the population aged 65 years and above is expected to increase from 46 million in 2014 to over 98 million by 2060. With increasing geriatric population, prevalence of aneurysm is also expected to increase.

Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/1339

Key players operating in endovascular aneurysm market include Medtronic plc. Cook Medical, Gore Medical, B. Braun Melsungen AG, Terumo Corporation, Boston Scientific Corporation, Abbott Laboratories, Volcano Corporation, C.R. Bard, Spectranetics International BV, Cordis Corporation (Johnson and Johnson Co.), and St. Jude Medical Inc.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]